Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Conferences
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
naturereprints
About this site
For librarians
 
NPG Resources
Bioentrepreneur
Nature Reviews Drug Discovery
Nature
Nature Medicine
Nature Genetics
Nature Reviews Genetics
Nature Methods
Nature Chemical Biology
news@nature.com
Clinical Pharmacology & Therapeutics
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Letters
Nature Biotechnology 24, 351 - 357 (2006)
Published online: 26 February 2006; | doi:10.1038/nbt1197

CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells

Daniella Herszfeld1, 5, Ernst Wolvetang1, 5, Emma Langton-Bunker1, Tung-Liang Chung1, Adam A Filipczyk1, Souheir Houssami1, Pegah Jamshidi1, Karen Koh1, Andrew L Laslett1, Anna Michalska1, Linh Nguyen1, Benjamin E Reubinoff1, 4, Irene Tellis1, Jonathan M Auerbach2, Carol J Ording2, Leendert H J Looijenga3 & Martin F Pera1

1  Monash Institute of Medical Research, Monash University, and the Australian Stem Cell Centre, Bldg. 75 STRIP, Wellington Road, Clayton, Victoria 3800 Australia.

2  Stem Cell Center, American Type Culture Collection, 10801 University Boulevard, Manassas, Virginia 20110, USA.

3  Pathology/Lab. Exp. Patho-Oncology, Erasmus MC–University Medical Center Rotterdam, Daniel den Hoed Cancer Center, Josephine Nefkens Institute, Building Be, Room 430b, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands.

4  Present address: The Hadassah Human Embryonic Stem Cell Research Center, The Goldyne Savad Institute of Gene Therapy and The Department of Gynecology, Hadassah University Hospital, Ein-Kerem, P.O.B. 12000, Jerusalem 91120, Israel.

5  These authors contributed equally to this work.

Correspondence should be addressed to Martin F Pera martin.pera@med.monash.edu.au

M83554M83554M83554D86042D86042The application of human embryonic stem (hES) cells in regenerative medicine will require rigorous quality control measures to ensure the safety of hES cell–derived grafts. During propagation in vitro, hES cells can acquire cytogenetic abnormalities1, 2, 3 as well as submicroscopic genetic lesions, such as small amplifications or deletions4. Many of the genetic abnormalities that arise in hES cell cultures are also implicated in human cancer development. The causes of genetic instability of hES cells in culture are poorly understood, and commonly used cytogenetic methods for detection of abnormal cells are capable only of low-throughput analysis on small numbers of cells. The identification of biomarkers of genetic instability in hES cells would greatly facilitate the development of culture methods that preserve genomic integrity. Here we show that CD30, a member of the tumor necrosis factor receptor superfamily, is expressed on transformed but not normal hES cells, and that CD30 expression protects hES cells against apoptosis.


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

The medium is the message

Nature Biotechnology News and Views (01 Feb 2006)

Stem cell culture, one step at a time

Nature Methods News and Views (01 Mar 2005)

See all 5 matches for News And Views
 Top
natureproducts

Natureproducts is an online service detailing information about specific products used in this article, you can view the product descriptions, request information and compare with other similar products. The products used are listed in alphabetical order.

A-Z product listingbiocompare
647 goat anti-mouse IgG2b (Alexa Fluor)
647 goat anti-mouse IgM (Alexa Fluor)
Alexa Fluor 546 (Molecular Probes)
Alexa Fluor 568 (Invitrogen)
Alexa Fluor 647 (Molecular Probes)
C-terminal epitope in CD30 (Santa Cruz Biotechnology)
See more natureproducts
 Top
 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
rights and permissionsRights and permissions
Order commercial reprintsOrder commercial reprints
CrossRef lists 30 articles citing this articleCrossRef lists 30 articles citing this article
Save this linkSave this link
Competing financial interests
Figures & Tables
Supplementary info
Products
See also: News and Views by Andrews
Export citation

Open Innovation Challenges

naturejobs

natureproducts

Search buyers guide:

 
Nature Biotechnology
ISSN: 1087-0156
EISSN: 1546-1696
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | Conferences | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2006 Nature Publishing Group | Privacy policy